Kolkata Woman Shows Mobility Improvement After Therapy In Navi Mumbai

A 28-year-old woman from Kolkata, who had been suffering from Sjögren’s syndrome, has shown significant improvement in mobility after undergoing cell-based therapy and rehabilitation at StemRx Hospital & Research Centre in Navi Mumbai.

The woman, Taniya Modak Paik, had developed severe neurological complications associated with the disease and had been wheelchair-dependent for nearly four years. Sjögren’s syndrome is an autoimmune disorder that affects the body’s moisture-producing glands, causing dry eyes and mouth, fatigue, joint and muscle pain, and numbness.

Taniya’s symptoms began in 2018 with an unusual pulling sensation while walking, and her condition gradually worsened over the years. Despite undergoing various treatments, including plasmapheresis, monoclonal antibody therapy, and Rituximab infusions, her mobility continued to deteriorate.

In 2025, Taniya consulted Dr Pradeep Mahajan, a regenerative medicine expert and founder of StemRx Hospital & Research Centre. She underwent an individualised programme combining cell-based therapy, exosome-based treatment, mitochondrial therapy, physiotherapy, rehabilitation, and nutritional support.

According to the hospital, Taniya reported significant improvement within 15 days of treatment, including reduced oral dryness, easier swallowing, less back pain and muscle stiffness, and improved mobility. She was able to get up from a chair more easily and take steps with support.

Dr Mahajan stated that Sjögren’s syndrome can affect the nervous system and cause ganglionopathy, leading to sensory loss, balance problems, stiffness, and difficulty walking. However, experts noted that the reported improvement is based on an individual case and does not establish that cell-based therapy can cure Sjögren’s syndrome or its neurological complications.

Taniya has been discharged from the hospital and advised to continue regular physiotherapy, follow-up, and medical supervision. The improvement in her condition has restored her confidence after years of losing her independence.

Sjögren’s syndrome affects around 0.1%–1% of the population, and there is currently no cure for the disease. While Taniya’s case is a positive development, longer-term follow-up and clinical evidence are needed to assess the durability and effectiveness of cell-based therapy for Sjögren’s syndrome.

The treatment of Sjögren’s syndrome is complex and requires a multidisciplinary approach. Patients with the disease often require ongoing medical care and support to manage their symptoms and prevent complications.

In conclusion, Taniya’s case highlights the potential benefits of cell-based therapy and rehabilitation for patients with Sjögren’s syndrome. However, further research is needed to fully understand the effectiveness of this treatment approach and to develop new therapies for this debilitating disease.

The improvement in Taniya’s condition is a significant development for patients with Sjögren’s syndrome, and it highlights the importance of ongoing medical research and innovation in the field of regenerative medicine. As research continues to advance, there is hope that new and effective treatments will be developed to improve the lives of patients with this disease.

The case also underscores the importance of seeking medical attention and exploring available treatment options for patients with Sjögren’s syndrome. With the right treatment and support, patients can experience significant improvements in their symptoms and quality of life.

In the future, it is likely that cell-based therapy and other innovative treatments will play an increasingly important role in the management of Sjögren’s syndrome. As the medical community continues to learn more about the disease and its treatment, patients can expect to see new and effective therapies emerge.

Overall, Taniya’s story is a testament to the power of medical innovation and the importance of ongoing research and development in the field of regenerative medicine. It is a reminder that there is always hope for patients with debilitating diseases, and that with the right treatment and support, they can experience significant improvements in their symptoms and quality of life.

The significance of this development for Mumbai and India is that it highlights the importance of investing in medical research and innovation. By supporting the development of new and effective treatments, we can improve the lives of patients with debilitating diseases and enhance the overall quality of healthcare in our country.

In terms of the broader implications of this development, it is clear that cell-based therapy and other innovative treatments have the potential to revolutionize the management of Sjögren’s syndrome and other autoimmune disorders. As research continues to advance, we can expect to see new and effective therapies emerge, and patients can look forward to experiencing significant improvements in their symptoms and quality of life.

In conclusion, the improvement in Taniya’s condition is a significant development for patients with Sjögren’s syndrome, and it highlights the importance of ongoing medical research and innovation in the field of regenerative medicine. It is a reminder that there is always hope for patients with debilitating diseases, and that with the right treatment and support, they can experience significant improvements in their symptoms and quality of life.